How AstraZeneca Is Managing Their Extractables And Leachables Data

By Jesse Harris, Digital Marketing Coordinator, ACD/Labs

Container-closure systems are easy to overlook, but their materials can interact with medicines in ways that impact safety and efficacy. Extractables and leachables (E&L) research brings together chemistry, toxicology, and materials science to identify and mitigate these risks. Yet scientists often face fragmented data spread across formats and organizations, slowing progress. A collaborative effort within the ELSIE consortium has led to a searchable, pre‑competitive knowledge base designed to standardize and share E&L insights. With perspective from AstraZeneca’s Stephen Warren, explore how this resource is shaping better decision-making, improving data accessibility, and advancing safer pharmaceutical development practices.

Read the full article to discover how unified knowledge can reduce uncertainty and accelerate your E&L workflows.